ALNYLAM PHARMACEUTICALS, INC. ($ALNY)
Fitzgerald Kevin Joseph โ CSO & EVP, Head of Research
Shares
8,105
Price
$0.00
Total Value
$0.00
Nearby Earnings
No earnings within 2 weeks of this transaction.
Transaction Details
| Insider | Fitzgerald Kevin Joseph |
|---|---|
| Title | CSO & EVP, Head of Research |
| Transaction Date | Mar 2, 2026 |
| Expiration Date | Mar 2, 2036 |
| Transaction Code | A Grant/Award |
| Acquired/Disposed | Acquired |
| Security | Stock Option (right to buy) |
| Derivative | Yes |
| Direct/Indirect | Direct |
| Filing Date | Mar 5, 2026 |
| Shares Purchased | 8,105 |
| Price per Share | $0.00 |
| Total Value | $0.00 |
| Shares Owned After | 8,105 |
| Derivative | Derivative |
| Accession Number | 0001735276-26-000051 |
| Document | View SEC Filing |